Omalizumab in the treatment of adult patients with mastocytosis: A systematic review.

Jendoubi, Fatma; Gaudenzio, Nicolas; Gallini, Adeline; Negretto, Mathilde; Paul, Carle; Bulai Livideanu, Cristina

Jendoubi, Fatma; Gaudenzio, Nicolas; Gallini, Adeline; Negretto, Mathilde; Paul, Carle; Bulai Livideanu, Cristina.

Afiliação

Jendoubi F; Department of Dermatology, Mastocytosis National Reference Center (CEREMAST), Toulouse University Hospital, Toulouse, France.
Gaudenzio N; UDEAR - Hôpital Purpan, UMR 1056 INSERM - University of Toulouse, Toulouse, France.
Gallini A; Department of Epidemiology and Public Health, UMR1027, INSERM-University of Toulouse, Toulouse, France.
Negretto M; Department of Dermatology, Mastocytosis National Reference Center (CEREMAST), Toulouse University Hospital, Toulouse, France.
Paul C; Department of Dermatology, Mastocytosis National Reference Center (CEREMAST), Toulouse University Hospital, Toulouse, France.
Bulai Livideanu C; Department of Dermatology, Mastocytosis National Reference Center (CEREMAST), Toulouse University Hospital, Toulouse, France.

Clin Exp Allergy ; 50(6): 654-661, 2020 06.

Article em En | MEDLINE | ID: mdl-32107810

Assuntos

Mastocitose/tratamento farmacológico; Omalizumab/uso terapêutico; Adulto; Feminino; Humanos; Masculino; Mastocitose/imunologia; Mastocitose/patologia; Pessoa de Meia-Idade

Palavras-chave

Omalizumab; anaphylaxis; cutaneous mastocytosis; mast cells; systemic mastocytosis; venom and insect allergy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mastocitose / Omalizumab Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google